Clinical Trial Update: Text Messaging and Atopic Dermatitis [NA]

View source ↗

Summary

Clinical trial NCT01216059 investigated a text messaging intervention for Atopic Dermatitis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Northwestern University | Conditions: Atopic Dermatitis | NA | Status: COMPLETED